Friday, December 23, 2016 Written by David Persing M.D., Ph.D., Chief Medical and Technology Officer, Cepheid

From the Editor

In this issue of On Demand, Dr. Ellen Jo Baron provides a comprehensive summary of the public health challenge posed by Group B Streptococcus (GBS) and the “Test and Treat” strategies that have been highly effective in interrupting transmission of this pathogen. Cepheid is pleased to be able to offer comprehensive GBS testing options for the antepartum and intrapartum setting; our most recently cleared GBS testing option, Xpert® GBS LB, combines ease of use with superior sensitivity. We think you will find this issue to be highly informative.